Results 301 to 310 of about 1,540,879 (346)
Some of the next articles are maybe not open access.
Inadvertent Intravitreal Gentamicin Injection
European Journal of Ophthalmology, 2002Purpose To describe the management and consequences of an accidental injection of gentamicin in the vitreous. Methods A retinal detachment developed in a 70-year-old male. During a vitrectomy operation, gentamicin (20mg) was accidentally injected in to the eye.
Z, Burgansky, T, Rock, E, Bartov
openaire +2 more sources
Complications of intravitreal injections: 2022
Current Opinion in Ophthalmology, 2022Purpose of review This review highlights the complications of both intravitreal injection procedure as well as different intravitreal medications including antivascular endothelial growth factors, antibiotics, antivirals, antifungals, methotrexate, and steroids.
Dillan, Patel +3 more
openaire +2 more sources
Intravitreal Injection--Technique and Safety.
Intravitreal (IVT) injection of therapeutic agents has become one of the most commonly performed procedures in ophthalmology. Over the past decade, a number of guidelines have been published that recommend proper techniques to increase the safety of IVT injections.
T. Lai, Shu Liu, Sudipta Das, D. Lam
semanticscholar +3 more sources
Intravitreal Injection of Piperacillin
Ophthalmic Surgery, Lasers and Imaging Retina, 1989ABSTRACT Piperacillin was injected into the vitreous body of rabbit eyes to evaluate its suitability for intraocular injection and its toxicity on intraocular tissues. Doses ranged from 50 µg to 3,000 µg. Toxicity was determined through histology and electroretinograms by comparing the piperacillin-injected eyes with eyes injected with ...
H C, Semple, J C, Liu, G A, Peyman
openaire +2 more sources
Complications of intravitreal injections
Current Opinion in Ophthalmology, 2010Over the past few years, the results of many studies have highlighted the risks and benefits of intravitreal injection of a number of medications, the most common being triamcinolone, antivascular endothelial growth factor (VEGF) agents, antibiotics, antivirals, antifungals, and methotrexate. The purpose of this review is to highlight the complications
Sampat, Kapil M., Garg, Sunir J.
openaire +2 more sources
Ocular hypertension after intravitreal injections
Vestnik oftal'mologii, 2022Intravitreal injections (IVI) of anti-vascular endothelial growth factor (anti-VEGF) for the treatment of age-related macular degeneration with choroidal neovascularization have become much more popular nowadays. Anti-VEGF therapy is generally well-tolerated; however, one of its possible side effects is ocular hypertension - elevation of intraocular ...
V.P. Erichev +2 more
openaire +2 more sources
Intravitreal Silicone Oil Droplets After Intravitreal Drug Injections
Retina, 2008To present the finding of tiny silicone oil droplets in 15 eyes of 15 patients after intravitreal injections of an anti-vascular endothelial growth factor agent or triamcinolone acetonide and to discuss the likely source of silicone oil.In an observational case series, charts of patients who had undergone intravitreal injections by one surgeon were ...
Sophie J, Bakri, Noha S, Ekdawi
openaire +2 more sources
Ocular Pain After Intravitreal Injection
Current Eye Research, 2013To evaluate the efficacy of different anesthetics and topical anti-inflammatory treatment in patients undergoing intravitreal injections (IVI).Prospective, randomized, double masked, comparative study. Patients undergoing 0.05 mL IVI were randomized to two different preoperative anesthetic regimes (regime A [0.5% tetracaine + naphazoline] versus regime
Maria Rosa, Sanabria +7 more
openaire +2 more sources
EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS
Retina, 2004Intravitreous (i.v.t.) injection is increasingly being incorporated into the management of ocular diseases. While only fomivirsen sodium (Vitravene) is currently approved by the Food and Drug Administration as an i.v.t. injection, the number of approved i.v.t.
Lloyd P, Aiello +13 more
openaire +2 more sources
Angioedema after intravitreal bevacizumab injection
Cutaneous and Ocular Toxicology, 2012A 47-year-old male with a history of diabetes mellitus type 2 exhibited with decreased vision in both eyes. The diagnosis of cystoid macular edema (CME) was made and it was decided to administer bilateral intravitreal bevacizumab (Avastin) injections. After intravitreal bevacizumab injection (1.25 mg/0.05 cc) to the right eye the patient had angioedema
Yasin, Toklu +3 more
openaire +2 more sources

